Logo image of HNRG

HALLADOR ENERGY CO (HNRG) Stock Fundamental Analysis

NASDAQ:HNRG - Nasdaq - US40609P1057 - Common Stock - Currency: USD

16.88  -0.23 (-1.34%)

Fundamental Rating

3

HNRG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 213 industry peers in the Oil, Gas & Consumable Fuels industry. While HNRG seems to be doing ok healthwise, there are quite some concerns on its profitability. HNRG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HNRG has reported negative net income.
HNRG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HNRG reported negative net income in multiple years.
In the past 5 years HNRG always reported a positive cash flow from operatings.
HNRG Yearly Net Income VS EBIT VS OCF VS FCFHNRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

HNRG has a worse Return On Assets (-58.58%) than 96.24% of its industry peers.
The Return On Equity of HNRG (-185.93%) is worse than 90.61% of its industry peers.
HNRG has a Return On Invested Capital (5.23%) which is in line with its industry peers.
Industry RankSector Rank
ROA -58.58%
ROE -185.93%
ROIC 5.23%
ROA(3y)-16.84%
ROA(5y)-10.64%
ROE(3y)-63.69%
ROE(5y)-39.29%
ROIC(3y)N/A
ROIC(5y)N/A
HNRG Yearly ROA, ROE, ROICHNRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

Looking at the Operating Margin, with a value of 2.66%, HNRG is doing worse than 71.36% of the companies in the same industry.
HNRG has a Gross Margin (43.45%) which is in line with its industry peers.
In the last couple of years the Gross Margin of HNRG has grown nicely.
Industry RankSector Rank
OM 2.66%
PM (TTM) N/A
GM 43.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y26.26%
GM growth 5Y11.99%
HNRG Yearly Profit, Operating, Gross MarginsHNRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HNRG is destroying value.
The number of shares outstanding for HNRG has been increased compared to 1 year ago.
HNRG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HNRG has been reduced compared to a year ago.
HNRG Yearly Shares OutstandingHNRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HNRG Yearly Total Debt VS Total AssetsHNRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.45 indicates that HNRG is not a great score, but indicates only limited risk for bankruptcy at the moment.
HNRG has a Altman-Z score of 2.45. This is in the better half of the industry: HNRG outperforms 76.06% of its industry peers.
The Debt to FCF ratio of HNRG is 0.92, which is an excellent value as it means it would take HNRG, only 0.92 years of fcf income to pay off all of its debts.
HNRG has a Debt to FCF ratio of 0.92. This is amongst the best in the industry. HNRG outperforms 89.67% of its industry peers.
A Debt/Equity ratio of 0.09 indicates that HNRG is not too dependend on debt financing.
The Debt to Equity ratio of HNRG (0.09) is better than 76.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.92
Altman-Z 2.45
ROIC/WACC0.53
WACC9.88%
HNRG Yearly LT Debt VS Equity VS FCFHNRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 0.60 indicates that HNRG may have some problems paying its short term obligations.
With a Current ratio value of 0.60, HNRG is not doing good in the industry: 80.28% of the companies in the same industry are doing better.
HNRG has a Quick Ratio of 0.60. This is a bad value and indicates that HNRG is not financially healthy enough and could expect problems in meeting its short term obligations.
HNRG has a worse Quick ratio (0.17) than 93.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.17
HNRG Yearly Current Assets VS Current LiabilitesHNRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for HNRG have decreased strongly by -123.73% in the last year.
HNRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.61%.
HNRG shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.76% yearly.
EPS 1Y (TTM)-123.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%580%
Revenue 1Y (TTM)-26.61%
Revenue growth 3Y17.75%
Revenue growth 5Y4.76%
Sales Q2Q%7.4%

3.2 Future

Based on estimates for the next years, HNRG will show a very strong growth in Earnings Per Share. The EPS will grow by 40.93% on average per year.
HNRG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.70% yearly.
EPS Next Y-49.44%
EPS Next 2Y78.5%
EPS Next 3Y64.4%
EPS Next 5Y40.93%
Revenue Next Year-1.37%
Revenue Next 2Y10.79%
Revenue Next 3Y11.91%
Revenue Next 5Y6.7%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HNRG Yearly Revenue VS EstimatesHNRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
HNRG Yearly EPS VS EstimatesHNRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HNRG. In the last year negative earnings were reported.
HNRG is valuated quite expensively with a Price/Forward Earnings ratio of 33.10.
Based on the Price/Forward Earnings ratio, HNRG is valued a bit more expensive than the industry average as 65.26% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.17. HNRG is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 33.1
HNRG Price Earnings VS Forward Price EarningsHNRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

HNRG's Enterprise Value to EBITDA is on the same level as the industry average.
HNRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.19
EV/EBITDA 10.04
HNRG Per share dataHNRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

HNRG's earnings are expected to grow with 64.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y78.5%
EPS Next 3Y64.4%

0

5. Dividend

5.1 Amount

No dividends for HNRG!.
Industry RankSector Rank
Dividend Yield N/A

HALLADOR ENERGY CO

NASDAQ:HNRG (6/4/2025, 8:00:01 PM)

16.88

-0.23 (-1.34%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners57.06%
Inst Owner Change12.99%
Ins Owners10.4%
Ins Owner Change1.53%
Market Cap725.50M
Analysts82.86
Price Target15.3 (-9.36%)
Short Float %7.17%
Short Ratio2.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)116.31%
Min EPS beat(2)-14.44%
Max EPS beat(2)247.06%
EPS beat(4)2
Avg EPS beat(4)35.24%
Min EPS beat(4)-230.88%
Max EPS beat(4)247.06%
EPS beat(8)4
Avg EPS beat(8)6.96%
EPS beat(12)6
Avg EPS beat(12)30.57%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)6.89%
Min Revenue beat(2)-3.23%
Max Revenue beat(2)17%
Revenue beat(4)1
Avg Revenue beat(4)-3.94%
Min Revenue beat(4)-17.47%
Max Revenue beat(4)17%
Revenue beat(8)3
Avg Revenue beat(8)-3.52%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)6.25%
EPS NQ rev (3m)-65.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-686.05%
Revenue NQ rev (1m)-12.01%
Revenue NQ rev (3m)21.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.1
P/S 1.78
P/FCF 19.19
P/OCF 8.25
P/B 6.29
P/tB 6.29
EV/EBITDA 10.04
EPS(TTM)-0.14
EYN/A
EPS(NY)0.51
Fwd EY3.02%
FCF(TTM)0.88
FCFY5.21%
OCF(TTM)2.05
OCFY12.13%
SpS9.49
BVpS2.68
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -58.58%
ROE -185.93%
ROCE 5.75%
ROIC 5.23%
ROICexc 5.42%
ROICexgc 5.42%
OM 2.66%
PM (TTM) N/A
GM 43.45%
FCFM 9.27%
ROA(3y)-16.84%
ROA(5y)-10.64%
ROE(3y)-63.69%
ROE(5y)-39.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y26.26%
GM growth 5Y11.99%
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.92
Debt/EBITDA 0.14
Cap/Depr 77.02%
Cap/Sales 12.3%
Interest Coverage 1.17
Cash Conversion 115.73%
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.17
Altman-Z 2.45
F-Score6
WACC9.88%
ROIC/WACC0.53
Cap/Depr(3y)102.89%
Cap/Depr(5y)86.21%
Cap/Sales(3y)13.33%
Cap/Sales(5y)11.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%580%
EPS Next Y-49.44%
EPS Next 2Y78.5%
EPS Next 3Y64.4%
EPS Next 5Y40.93%
Revenue 1Y (TTM)-26.61%
Revenue growth 3Y17.75%
Revenue growth 5Y4.76%
Sales Q2Q%7.4%
Revenue Next Year-1.37%
Revenue Next 2Y10.79%
Revenue Next 3Y11.91%
Revenue Next 5Y6.7%
EBIT growth 1Y-71.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year864.58%
EBIT Next 3Y184.99%
EBIT Next 5Y113.38%
FCF growth 1Y100.2%
FCF growth 3Y-14.23%
FCF growth 5Y35.91%
OCF growth 1Y13.82%
OCF growth 3Y11.19%
OCF growth 5Y11.51%